|
Haig Bozigian, Ph.D., Senior Vice President of Pharmaceutical and Preclinical Development. Haig has the responsibilities of all preclinical, chemical and pharmaceutical development. With extensive expertise in CNS related new product development, Dr. Bozigian has participated in the research and development of more than 15 INDs and 5 NDAs. From 1997 to 2006, Dr. Bozigian held several positions at Neurocrine, most recently as Vice President of Preclinical Development. Prior to joining Neurocrine, Dr. Bozigian served as Director of Pharmaceutical Development at Procyte Corporation, Associate Director of Pharmacokinetics and Drug Metabolism at Sphinx Pharmaceuticals and as a clinical pharmacokineticist at GlaxoSmithKline. Dr. Bozigian earned his B.S. in microbiology from the University of Massachusetts, his M.S. in pharmacodynamics and toxicology from the University of Nebraska Medical Center, and earned his Ph.D. in pharmaceutical sciences from the University of Arizona. | 